SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-22-222510
Filing Date
2022-08-17
Accepted
2022-08-16 20:51:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d291233d424b3.htm 424B3 2822
2 GRAPHIC g291233g0815025752925.jpg GRAPHIC 3052
  Complete submission text file 0001193125-22-222510.txt   8508
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-260859 | Film No.: 221171854
SIC: 8071 Services-Medical Laboratories